Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: Comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI

Journal of the Chinese Medical Association

Volumn 74, Issue 2, 2011, Pages 62-68

  Chou, Chen Te ^a,c   Chen, Ran Chou ^a,b   Chen, Wei Tsung ^b   Lii, Jiunn Ming ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Dysplastic nodule; Ferucarbotran; Gadolinium; Hepatocellular carcinoma; T1 weighted hyperintense nodule

Indexed keywords

FERUCARBOTRAN; GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DEXTRANS; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79951945874     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.01.013     Document Type: Article

References (22)

1. Sakamoto M., Hirohashi S., Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991, 22:172-178.
2. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
3. Koslow S.A., Davis P.L., DeMarino G.B., Peel R.L., Baron R.L., Van Thiel D.H. Hyperintense cirrhotic nodules on MRI. Gastrointest Radiol 1991, 16:339-341.
4. Krinsky G.A., Israel G. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol 2003, 180:1023-1027.
5. Earls J.P., Theise N.D., Weinreb J.C., DeCorato D.R., Krinsky G.A., Rofsky N.M., et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996, 201:207-214.
6. Efremidis S.C., Hytiroglou P., Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007, 17:2969-2982.
7. Tanimoto A., Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006, 58:200-216.
8. Krinsky G.A., Lee V.S., Theise N.D., Weinreb J.C., Rofsky N.M., Diflo T., et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001, 219:445-454.
9. Yu J.S., Kim Y.H., Rofsky N.M. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images. J Comput Assist Tomogr 2005, 29:51-58.
10. Imai Y., Murakami T., Yoshida S., Nishikawa M., Ohsawa M., Tokunaga K., et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000, 32:205-212.
11. Arbab A.S., Ichikawa T., Araki T., Toyama K., Nambu A., Ohsawa S., et al. Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide (SHU-555-A). Abdom Imaging 2000, 25:151-158.
12. Chou C.T., Chen R.C., Chen W.T., Lii J.M. Detection of hepatocellular carcinoma by Ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging. Clin Radiol 2009, 64:22-29.
13. Lee J.M., Kim C.S., Youk J.H., Lee M.S. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Korean J Radiol 2003, 4:9-18.
14. Li C.S., Chen R.C., Lii J.M., Chen W.T., Shih L.S., Zhang T.A., et al. Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma. J Comput Assist Tomogr 2006, 30:597-603.
15. Lencioni R., Cioni D., Della Pina C., Crocetti L., Bartolozzi C. Imaging diagnosis. Semin Liver Dis 2005, 25:162-170.
16. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
17. Forner A., Vilana R., Ayuso C., Bianchi L., Solé M., Ayuso J.R., et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
18. Miyaaki H., Fujimoto M., Kurogi M., Nakashima O., Eguchi K., Kojiro M. Pathomorphological study on small nodular lesions in hepatitis C virus-related cirrhosis. Oncol Rep 2005, 14:1469-1474.
19. Hamm B., Staks T., Taupitz M. SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol 1994, 29(Suppl 2):S87-S89.
20. Koushima Y., Ebara M., Fukuda H., Morimoto N., Sugiura N., Yoshikawa M., et al. Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression. Eur J Radiol 2002, 41:34-41.
21. Hill K.A., Nayar R., DeFrias D.V. Cytohistologic correlation of cirrhosis and hepatocellular carcinoma: Pitfall in diagnosis?. Acta Cytol 2004, 48:127-132.
22. Kobayashi M., Ikeda K., Hosaka T., Sezaki H., Someya T., Akuta N., et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 2006, 106:636-647.